Perrigo Company plc Legal Fees
Perrigo Company plc (PRGO) reported Legal Fees of $71.30 million for the 3-month period ending 2015-12-31, per its 10-K filed 2018-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LegalFees · last filed 2018-03-01
- Perrigo Company plc legal fees for the quarter ending 2015-12-31 was $71.30M.
- Perrigo Company plc legal fees for the quarter ending 2015-09-26 was $15.60M.
- Perrigo Company plc legal fees for the quarter ending 2015-06-27 was $13.40M.
| Period end | Legal Fees 3 month | Legal Fees 6 month | Legal Fees 9 month |
|---|---|---|---|
| 2015-12-31 | $71.30M 10-K · filed 2018-03-01 | $86.90M derived: sum of 2 quarters · filed 2018-03-01 | $100.30M derived: sum of 3 quarters · filed 2018-03-01 |
| 2015-09-26 | $15.60M 10-K · filed 2018-03-01 | $29.00M derived: sum of 2 quarters · filed 2018-03-01 | |
| 2015-06-27 | $13.40M 10-K · filed 2017-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |